Ads
related to: Enbrel- Is RINVOQ Right For You?
RINVOQ® Could Be Right For You.
See RINVOQ® Clinical Trial Results.
- What Is RINVOQ®?
Learn About The FDA-Approved
Oral Pill.
- Watch Video
What Is RINVOQ®?
Watch A Video To Learn More.
- Register For More Info
Sign Up For More
Information About RINVOQ®.
- Treatment Didn't Help?
Looking To Change Treatments?
RINVOQ® Could Be The Right Fit.
- Talk With Your Doctor
Get Talking Tips To Guide
Conversation With Your Doctor.
- Is RINVOQ Right For You?
Search results
Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts
Investor's Business Daily· 2 years agoAmgen stock popped Friday after the drugmaker sweetened its 2022 outlook following a third-quarter...
Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
Zacks via Yahoo Finance· 1 year agoPfizer PFE reported fourth-quarter 2022 adjusted earnings per share of $1.14, which significantly...
Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoPfizer PFE will report third-quarter 2022 results on Nov 1, before market open. In the last reported...
Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 3 months agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 3 months agoFor more than a century, American investors have looked to the Dow Jones Industrial Average...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 9 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
Amgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryx
Investor's Business Daily· 2 years agoAmgen stock dipped Friday after the company narrowed its 2022 outlook and announced its $3.7 billion...
FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source
Reuters via Yahoo Finance· 1 year agoAmgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. Amgen...
Hundreds of Medications, Including Ozempic and Mounjaro, Have Increased in Price in 2024, Research...
People via Yahoo News· 4 months agoOther drugs that rose in price this year include the pain medication Oxycontin and the...
Ads
related to: Enbrel